• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Cell biophysics

    Cell biophysics

    JournalISSN 0163-4992

    年发文量

    研究主题

    论文(4028)

    排序
    1Lutein Targets TLR4 As a Potential Immunotherapeutic Strategy for Treatment of Doxorubicin-Induced Cardiomyopathy
    Eman G. Khedr, Noha H. Badr,Ola A. El-Feky

    Toll-like receptor 4 is an immune receptor associated with inflammatory diseases, including cardiac conditions. Lutein, a natural carotenoid with potent anti-inflammatory effects, protects against coronary heart disease and other cardiovascular issues. We aimed to explore its potential cardioprotective effects against doxorubicin-induced cardiomyopathy (DIC), focusing on the TLR4/NF-κB and JAK/STAT pathways. We compared its effects with olmesartan, commonly used to manage DIC. This study was performed on five groups of rats: control, doxorubicin (Dox)-treated, lutein-treated, olmesartan-treated, and combination-treated groups. Induction of DIC was performed using Dox (4.5 mg/kg every other day) for ten days. In treatment groups, lutein (50 mg/kg/day) or olmesartan (10 mg/kg/day) was administered for 10 days alongside Dox, while the combination treatment group co-administered lutein (50 mg/kg/day) and olmesartan (10 mg/kg/day) for the same duration alongside Dox. The results indicated that lutein protected cardiomyocytes from Dox-induced histopathological changes, including myocardial fiber disorganization, vascular congestion, and perivascular edema. It decreased the levels of TLR4, NF-κB, p-JAK2, and p-STAT1/3 relative to the Dox group, exhibiting an anti-inflammatory effect through suppression of the TLR4/NF-κB and JAK/STAT pathways. It also had regulatory effects on Akt/mTOR signaling, another pathway linked to TLR4 activation. In comparison to olmesartan, lutein had superior effects on IL-6/JAK2/STAT1/NF-κB and Akt/mTOR levels. Combination treatment also demonstrated cardioprotective effect at histopathological, biochemical, and molecular levels, being more effective than olmesartan on IL-6/NF-κB and Akt/mTOR levels. Moreover, Lutein administration alongside Dox showed anti-inflammatory and cardioprotective effects against DIC, suggesting it as a promising adjunct therapy, either alone or with olmesartan.

    2026
    引用
    AI阅读
    加入学术空间
    2Second-Generation Combined Oral Contraceptives Induce Early Cardiovascular Risk Through Inflammatory and Oxidative Vascular Remodeling
    M O Allen, S A Salami, O M Olumide, O A Lawal-Bamidele, B A Murtala

    Second-generation combined oral contraceptive pills (COCPs), particularly formulations containing ethinylestradiol and levonorgestrel, remain widely used because of their effectiveness and affordability in middle and low-income countries. However, concerns persist about their cardiovascular safety. This study investigated the dose-dependent effects of a second-generation COCP on systolic blood pressure (SBP), inflammatory biomarkers, oxidative stress, vascular mediators, and vascular histology in female Sprague–Dawley rats. Twenty-four female Sprague–Dawley rats were acclimatized and randomly assigned to control, low-dose (1.1 µg/kg/day), and high-dose COCP (11 µg/kg/day) groups. Treatments were administered orally for six weeks. SBP and body weight were monitored before and after treatment. Serum C-reactive protein (CRP), tumour necrosis factor-alpha (TNF-α), and lipid profile were measured. Renal vascular homogenates were analyzed for nuclear factor kappa B (NF-κB), endothelin-1 (ET-1), nitric oxide (NO), malondialdehyde (MDA), superoxide dismutase, catalase (CAT), and glutathione. Histological examination was performed on the renal and thoracic arteries. The SBP increased by 4.6

    2026
    引用
    AI阅读
    加入学术空间
    3Divergent Immunometabolic Regulatory Networks Mediated by FOXO3 During Musculoskeletal Aging: Implications for Tissue-Adapted Precision Therapeutics
    Peng Zhang, Xiao Wang,Xiaotao Shi, Yanhao Yuan,Peizhao Wang, Renkun Zhao, Dongdong Xie,Honglüe Tan,Guorui Cao

    Musculoskeletal aging exhibits prominent tissue heterogeneity. Forkhead box O3 (FOXO3) acts as a master transcription factor orchestrating aging, metabolism and immune homeostasis. Existing mechanistic investigations are largely restricted to single tissues, and a head-to-head comparison of FOXO3-governed immunometabolic regulatory networks between knee osteoarthritis (KOA) synovium and aged skeletal muscle remains absent. A retrospective multi-cohort transcriptomic analysis was performed using datasets retrieved from the Gene Expression Omnibus (GEO) database. Two KOA synovial cohorts (GSE55235 and GSE55457, n = 40) and two aged skeletal muscle cohorts (GSE28422 and GSE25941, n = 146) were enrolled, covering a total of 186 tissue samples. We integrated differential expression analysis, random-effects meta-analysis, receiver operating characteristic (ROC) performance evaluation, single-sample gene set enrichment analysis (ssGSEA), and partial correlation analysis adjusted for disease confounding effects. A bootstrap-scoring system was further established to prioritize candidate therapeutic strategies. FOXO3 exhibited opposing expression patterns: it was downregulated in KOA synovium yet upregulated in aged skeletal muscle. The coupling profiles between FOXO3 and immune or metabolic pathways displayed striking tissue-specific divergence. In KOA synovium, FOXO3 expression was positively correlated with mitochondrial energy metabolism and macrophage infiltration, accompanied by selective inflammatory immune infiltration. By contrast, aged skeletal muscle resided in an immune-quiescent microenvironment, where elevated FOXO3 was strongly negatively coupled to oxidative metabolic pathways. Distinct intervention strategies were derived from these divergent network signatures: combined FOXO3 activation and metabolic modulation was recommended for KOA, whereas supplementation with nicotinamide adenine dinucleotide (NAD⁺) precursors constituted the primary intervention for aged skeletal muscle. Opposite FOXO3 expression levels correspond to fundamentally distinct immunometabolic network landscapes during musculoskeletal aging. The functional output of FOXO3 is dictated by the tissue microenvironment rather than its transcriptional abundance alone. This study supports stratified precision geriatric interventions via tissue-specific modulation of the FOXO3 pathway across divergent musculoskeletal aging contexts. Clinical trial number: Not applicable.

    2026
    引用
    AI阅读
    加入学术空间
    4Characterization of Anticancer Activities of Rhodiola Rosea L. Extracts in Breast Tumor Cells: Phenotype Changes and Potential Mechanisms of Action
    Sugandh Singh, Anita Kumari,Bramanandam Manavathi

    Rhodiola rosea L., a medicinal plant native to the high-altitude regions of the Indian Himalayas, contains diverse bioactive phytochemicals with broad pharmacological activities. This study investigated the anticancer activity and associated molecular responses of R. rosea root extracts in human breast cancer models. Commercial Rhodiola rosea root powder reconstituted in different solvents was evaluated for cytotoxicity against SK-BR-3, MDA-MB-231, and MCF-7 breast cancer cells, with HEK-293 cells serving as a non-malignant human reference model. The extracts exhibited concentration- and time-dependent cytotoxic effects, with differential sensitivity among breast cancer subtypes. MDA-MB-231 cells were subsequently selected for mechanistic investigations. Scratch wound-healing assays demonstrated reduced cell migration following extract treatment, accompanied by decreased expression of epithelial–mesenchymal transition (EMT)-associated proteins, including Snail, Slug, Vimentin, and N-Cadherin. Flow-cytometric analysis revealed extract-dependent redistribution of cells across the G0/G1, S, and G2/M phases, with dimethyl sulfoxide (DMSO)-solubilized R. rosea extract (RRD) and methanol-solubilized R. rosea extract (RRM) increasing the G0/G1 population and reducing the G2/M population, whereas ethanol-solubilized R. rosea extract (RRE) produced a distinct cell-cycle response. Gas chromatography–mass spectrometry (GC–MS) and liquid chromatography–mass spectrometry (LC–MS) profiling identified diverse phytochemical constituents in the extracts. Western blot analysis further demonstrated modulation of proteins involved in proliferation, cell-cycle regulation, apoptosis, tumor suppression, and EMT, including reduced hematopoietic PBX-interacting protein (HPIP)/protein kinase B (AKT) signaling, cellular myelocytomatosis oncogene (c-Myc), Cyclin A, Cyclin B, Fibrillarin (FBL), Aurora B, Snail, and Slug, together with increased phosphatase and tensin homolog (PTEN), phosphorylated retinoblastoma protein (pRb), AMP-activated protein kinase (AMPK), and cleaved Caspase-3. Collectively, these findings indicate that R. rosea extracts exert multifaceted anticancer effects through modulation of proliferative signaling, cell-cycle progression, apoptotic responses, and EMT-associated phenotypic changes.

    2026
    引用
    AI阅读
    加入学术空间
    5RNA-Based Biological Age Clocks Track Chronological Age in Skeletal Muscle but Show Limited Discrimination of Sarcopenia
    Sergio David Ledesma-Gallardo, Emma López-Espinosa,Alejandra Isabel Ortega-Meléndez, Eric Gustavo Ramírez-Salazar,Nelly Patiño,Berenice Rivera Paredez,Rafael Velázquez-Cruz,Alberto Hidalgo-Bravo,Rogelio Frank Jiménez-Ortega

    Transcriptomic biological age clocks may track age-related transcriptional variation in skeletal muscle, but it remains unclear whether they detect sarcopenia-related molecular variation beyond chronological age. This multicohort study benchmarked directly implementable RNA-based age models in public human skeletal muscle RNA-seq datasets. GSE164471 was used as a healthy-aging reference, GSE111006/GSE111010 as a pooled discovery benchmark, GSE167186 as external validation, and GSE174106 as biological validation using appendicular lean mass trajectories. RNAAgeCalc skeletal muscle and across-tissue models were implemented for age estimation and sarcopenia discrimination. Gene coverage was used only as a preliminary technical-compatibility assessment, after which the published SkeletAge model was directly applied to GSE111006 and GSE111010 for independent chronological-age prediction and sarcopenia-discrimination analyses; GSE164471, which contributed to SkeletAge model development, was used only for an in-sample implementation check. Both RNAAgeCalc models showed high gene coverage. In GSE164471, the skeletal muscle model showed stronger chronological-age tracking than the across-tissue model (r = 0.604 vs. 0.266; MAE 15.2 vs. 16.7 years), but retained substantial absolute prediction error and positive mean bias (+ 10.4 years), indicating that stronger correlation did not imply adequate calibration. In the discovery benchmark, between-group differences in chronological age, transcriptomic age, and age-acceleration residuals were not statistically significant, with small-to-moderate standardized effect estimates and confidence intervals spanning zero. Logistic discrimination was influenced mainly by cohort origin, while transcriptomic aging measures provided limited independent discrimination. External validation showed broad age-group structure with substantial overlap between old healthy and sarcopenic participants, and no differences were detected across appendicular lean mass trajectories. Current RNAAgeCalc implementations therefore appear to track chronological-age-related transcriptomic structure more effectively than sarcopenia-related variation, although smaller disease-related effects cannot be excluded, and these models should not currently be considered standalone sarcopenia biomarkers.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 4028 篇论文

    高被引作者

    作者引用发文
    Julia Brumaghim25073
    Nathan R. Perron19521
    Peiying Zhang142820
    Yi Zheng11685
    Lei Lu11685
    Min Liu11685
    Rongrong Sun11685
    ZiQi Tao9655
    Zhao Jing9572
    Aimin Shi9572

    高产作者

    作者引用发文
    Mahmoud Soliman33827
    Peiying Zhang142820
    Claudio Nicolini18717
    Armen Trchounian41215
    Periannan Kuppusamy20313
    Narasimham L Parinandi8311
    C. George Priya Doss13310
    Rizwan Hasan Khan69410
    Suresh C. Tyagi61810
    Kailin Xu1909

    相关期刊

    Advances in protein chemistry
    Free radical research
    Journal of Bioenergetics and Biomembranes
    Journal of cellular physiology. Supplement
    Redox report : communications in free radical research
    Biomagnetic research and technology
    Proteome science
    Archives of biochemistry
    PPAR research
    Biomolecular concepts